201. Pharmacological treatment of cardiogenic shock - A state of the art review.
- Author
-
Bruno RR, Wolff G, Kelm M, and Jung C
- Subjects
- Humans, Heart, Shock, Cardiogenic diagnosis, Shock, Cardiogenic drug therapy, Shock, Cardiogenic etiology, Heart Diseases
- Abstract
Cardiogenic shock is a clinical syndrome of impaired tissue perfusion caused by primary cardiac dysfunction and inadequate cardiac output. It represents one of the most lethal clinical conditions in intensive care medicine with mortality >40%. Management of different clinical presentations of cardiogenic shock includes guidance of cardiac preload, afterload, heart rate and contractility by differential pharmacological modulation of volume, systemic and pulmonary vascular resistance and cardiac output besides reversing the triggering cause. Data from large registries and randomized controlled trials on optimal diagnostic guidance as well as choice of pharmacological agents has accrued significantly in recent years. This state-of-the-art review summarizes the basic concepts of cardiogenic shock, the diagnostic work-up and currently available evidence and guideline recommendations on pharmacological treatment of cardiogenic shock., Competing Interests: Declaration of Competing Interest No conflicts to disclose., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF